Mar 18,2015

Pear Therapeutics Closes Financing

Pear Therapeutics, the creator of prescription pharmaceutical-software combination products called eFormulations, announced today that it has successfully closed on additional financing. The funding round was led by 5AM Ventures, with several undisclosed additional investors contributing capital. The investment will allow Pear to build a portfolio of eFormulationsTM.

FUNDING FUNDING ROUND

#virtual reality

#mobile app

View Analyst & Ambassador Comments
Go to original news
Aug 31,2015

LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution

LabStyle Innovations Corp., developer of the Dario Diabetes Management Solution, today announced it recently closed a round of funding totaling approximately $2.5 million. Funds will be used to support the global rollout and initial U.S. commercial launch of the Dario, a mobile, cloud-based, diabetes management solution that includes novel software applications combined with a stylish, 'all-in-one,' pocket-sized, blood glucose monitoring device, and for working capital purposes.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Jul 02,2019

AgaMatrix, Inc. and WaveForm Technologies, Inc. Complete $56 Million Capital Raise

AgaMatrix, Inc. (“AgaMatrix”) and WaveForm Technologies, Inc. (“WaveForm”), wholly owned subsidiaries of WaveForm Diabetes (formerly AgaMatrix Holdings, LLC), today announced that it closed on a total capital raise of $56 million. The raise includes over $6 million in financing from existing and new investors and $50 million in senior financing from Perceptive Advisors. The proceeds from the capital raise will be used for repayment of debt and to support increased production capacity, product development, and additional clinical trial initiatives for the commercialization of WaveForm’s Continuous Glucose Monitor (CGM) in Europe and FDA clearance in the USA.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Feb 17,2022

MindMaze Secures $105 million in Funding

MindMaze (“the Company”), a global pioneer in the multi-billion dollar digital neurotherapy market, today announced that it has secured a financing of USD 105 million to accelerate its plans for global commercial growth, boost ongoing R&D and consolidate its development pipeline covering a broad spectrum of neurological diseases. The funding was led by Concord Health Partners, a US-based private equity firm, alongside other investors such as AlbaCore Capital Group.

FUNDING FUNDING ROUND

#r&d

View Analyst & Ambassador Comments
Go to original news
Mar 15,2022

metaMe Health Raised $2.2 million Investment

Prescription digital therapeutic company metaMe Health raised $2.2 million in a bridge funding round led by Hyde Park Angels with participation from individual investors. The company will use the funding to prepare for the market launch of Regulora, a prescription digital therapeutic aimed at treating abdominal pain associated with irritable bowel syndrome in adults. The therapeutic received FDA 510(k) clearance late last year. metaMe said it plans to release Regulora in the second half of 2022.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Mar 15,2022

Woebot Health Secures $9.5 Million Investment From Leaps by Bayer

Woebot Health today announced that Leaps by Bayer, the impact investment arm of Bayer AG, has made a $9.5 million strategic investment in the company to help accelerate further development of its AI-powered behavioral health platform and products. The announcement follows Woebot Health’s $90 million Series B round in 2021 and brings total investment in the company to date to $123.5 million.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Apr 06,2022

Digital Therapeutics (DTx) Company Alex Therapeutics Raises $3.82 Million Funding

Stockholm-based Digital Therapeutics (DTx) company Alex Therapeutics announces it has secured a €3.5M funding round. The round was led by Hadean Ventures, a European specialist life science venture fund, with participation from Scale Capital and Bonit Capital, the Leksell (founder of medical device company Elekta) family office.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Aug 09,2021

S-Alpha Therapeutics, Inc., Digital Therapeutics Start-up Raises $8.7 Million in Series A Funding

S-Alpha Therapeutics, Inc., (“S-Alpha” CEO: Seung-Eun Choi), a startup dedicated in R&D for digital therapeutics, announced the completion of its Series A financing. S-Alpha Therapeutics raised a total of $8.7M USD (10 Billion KRW) in Series A financing round with the participation by existing investors and new Venture Capitalist (VC) funding. In 2020, S-Alpha Therapeutics raised $2.7M USD (3 Billion KRW) in seed round of funding from Hana Ventures, STIC Ventures, AJU IB Investment, SJ Investment Partners, and TONY Investment. In Series A funding, all existing investors participated in this investment, and Korea Investment Partners, Stonebridge Ventures, Devsisters Ventures/KDB Capital, and Timewise Investment participated as new investors.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Oct 08,2021

MindMaze scores $125M for game-like rehab treatment

Digital neurotherapeutic platform MindMaze has raised $125 million in funding from AlbaCore Capital Group. The company said it will use the new funds to speed commercialization and access to its rehab products, especially in North America and Europe. The capital will also allow it to expand its restorative products aimed at repairing brain damage, via more development and testing in clinical trials.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
May 09,2022

OncoHealth Secures Strategic Investments from Arsenal Capital Partners & McKesson Corporation

OncoHealth, the leading digital health company dedicated to oncology, announced today it has received strategic investments from Arsenal Capital Partners (“Arsenal”), a private equity firm specializing in building transformational healthcare businesses, and from McKesson Corporation (“McKesson”). The investments will support OncoHealth’s innovation and delivery of its oncology-specific digital health solutions for people with cancer, and Arsenal will take a majority ownership stake in the business. Additional financial terms of the transaction were not disclosed.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING ROUND